Citation: Bl. Robbins et al., Cellular phosphorylation of 2 ',3 '-dideoxyadenosine-5 '-monophosphate, a key intermediate in the activation of the antiviral agent DDI, in huhlan peripheral blood mononuclear cells, NUCLEOS NUC, 19(1-2), 2000, pp. 405-413
Authors:
Hughes, WT
Shenep, JL
Rodman, JH
Fridland, A
Willoughby, R
Blanchard, S
Purdue, L
Coakley, DF
Cundy, KC
Culnane, M
Zimmer, B
Burchett, S
Read, JS
Citation: Wt. Hughes et al., Single-dose pharmacokinetics and safety of the oral antiviral compound adefovir dipivoxil in children infected with human immunodeficiency virus type1, ANTIM AG CH, 44(4), 2000, pp. 1041-1046
Authors:
Schuetz, JD
Connelly, MC
Sun, DX
Paibir, SG
Flynn, PM
Srinivas, RV
Kumar, A
Fridland, A
Citation: Jd. Schuetz et al., MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs, NAT MED, 5(9), 1999, pp. 1048-1051
Authors:
Rodman, JH
Flynn, PM
Robbins, B
Jimenez, E
Bardeguez, AD
Rodriguez, JF
Blanchard, S
Fridland, A
Citation: Jh. Rodman et al., Systemic pharmacokinetics and cellular pharmacology of zidovudine in humanimmunodeficiency virus type 1-infected women and newborn infants, J INFEC DIS, 180(6), 1999, pp. 1844-1850
Authors:
Srinivas, RV
Middlemas, D
Flynn, P
Fridland, A
Citation: Rv. Srinivas et al., Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters, ANTIM AG CH, 42(12), 1998, pp. 3157-3162